Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 1 |
2023 | 1 |
2024 | 1 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Generation and Characterization of Trastuzumab/Pertuzumab-Resistant HER2-Positive Breast Cancer Cell Lines.
Int J Mol Sci. 2023 Dec 22;25(1):207. doi: 10.3390/ijms25010207.
Int J Mol Sci. 2023.
PMID: 38203378
Free PMC article.
NK cell-triggered CCL5/IFNγ-CXCL9/10 axis underlies the clinical efficacy of neoadjuvant anti-HER2 antibodies in breast cancer.
Santana-Hernández S, Suarez-Olmos J, Servitja S, Berenguer-Molins P, Costa-Garcia M, Comerma L, Rea A, Perera-Bel J, Menendez S, Arpí O, Bermejo B, Martínez MT, Cejalvo JM, Comino-Méndez I, Pascual J, Alba E, López-Botet M, Rojo F, Rovira A, Albanell J, Muntasell A.
Santana-Hernández S, et al.
J Exp Clin Cancer Res. 2024 Jan 3;43(1):10. doi: 10.1186/s13046-023-02918-4.
J Exp Clin Cancer Res. 2024.
PMID: 38167224
Free PMC article.
Item in Clipboard
Role of SALL4 in HER2+ Breast Cancer Progression: Regulating PI3K/AKT Pathway.
Pattanayak B, Lameirinhas A, Torres-Ruiz S, Burgués O, Rovira A, Martínez MT, Tapia M, Zazo S, Albanell J, Rojo F, Bermejo B, Eroles P.
Pattanayak B, et al.
Int J Mol Sci. 2022 Oct 31;23(21):13292. doi: 10.3390/ijms232113292.
Int J Mol Sci. 2022.
PMID: 36362083
Free PMC article.
Item in Clipboard
Cite
Cite